CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $83,000 | -19.4% | 33,952 | -1.2% | 0.07% | +124.2% |
| Q3 2015 | $103,000 | +19.8% | 34,352 | +64.7% | 0.03% | -53.5% |
| Q2 2015 | $86,000 | +17.8% | 20,852 | +23.7% | 0.07% | +16.4% |
| Q1 2015 | $73,000 | -3.9% | 16,852 | -26.3% | 0.06% | -23.8% |
| Q3 2014 | $76,000 | +117.1% | 22,852 | +65.6% | 0.08% | +166.7% |
| Q2 2014 | $35,000 | +25.0% | 13,800 | +12.2% | 0.03% | -11.8% |
| Q1 2014 | $28,000 | – | 12,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |